Sutro Biopharma Raises $36.5 Million
November 17, 2010
In its third round of venture funding, Sutro Biophoarma raised $36.5 million. The San Francisco company raised the money in two tranches -- the first one, worth $20 million, closed Nov. 5.
Skyline Ventures led this round and put Leon Chen on Sutro’s board of directors. Lilly Ventures and Amgen Ventures also gave money, with Lilly putting Armen Shanafelt on the board. Both are new investors. SV Life Sciences and Alta Partners, who have invested before, also gave money this time. The business has raised $59.5 million total.
William Newell is Sutro Biopharma’s CEO.
About
The Alliance of Chief Executives is an active community of business leaders that focuses on deep strategic exchanges, challenging existing assumptions and generating fresh ideas.
Contact Us
Alliance of Chief Executives, LLC
2175 N. California Blvd.,
Suite 605
Walnut Creek, CA 94596
- 925-942-2400 Office
- 925-956-4424 Fax
- Email: info@allianceofCEOs.com
Newsletter
Subscribe to our newsletter and stay up to date with the latest Alliance news!
About
The Alliance of Chief Executives is an active community of business leaders that focuses on deep strategic exchanges, challenging existing assumptions and generating fresh ideas.
Newsletter
Subscribe to our newsletter and stay up to date with the latest Alliance news!
Recent Member News
Member Resources
Contact Us
2175 N. California Blvd., Suite 605
Walnut Creek, CA 94596
925-942-2400 Office
925-956-4424 Fax
Email: info@allianceofCEOs.com
2026 © Alliance of Chief Executives, LLC
